A Contemporary Update of the Safety of Enhanced External Counterpulsation in Controlled Clinical Trials - Abstract
In the United States, approximately 10 million people suffer
from refractory angina and based on evidence from a recent
real-world analysis of a multi-payer database, 28% of patients
have recurring angina 1-year post-PCI [1].